{
  "pmcid": "7222856",
  "sha256": "021a02bfac0980f1c756798101117900323cad36133cba93f7b885b2fcdfa989",
  "timestamp_utc": "2025-11-09T22:54:00.196230+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.524117647058826,
    "reading_ease": 22.827462612163515,
    "word_count": 236
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial on the Impact of Residual Neuromuscular Block on Postoperative Pulmonary Complications"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "The sample size was calculated to ensure adequate power to detect differences in PPCs."
      },
      "Participants": {
        "score": 2,
        "evidence": "participants meeting specific eligibility criteria, recruited from a surgical setting"
      },
      "Intervention": {
        "score": 2,
        "evidence": "intervention group, receiving enhanced neuromuscular monitoring and management, or the control group, receiving standard care"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the effect of residual neuromuscular block (NMB) on postoperative pulmonary complications (PPCs)"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was the incidence of PPCs within 30 days post-surgery."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was achieved using a computer-generated sequence, with allocation concealment ensured through sealed envelopes."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 200 participants were randomised, with 100 in each group."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "Analysis was conducted on 98 participants in the intervention group and 97 in the control group using an intention-to-treat approach."
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The intervention group showed a significant reduction in PPCs (mean difference = 5.2%, 95% CI 3.1 to 7.3; p = 0.01)."
      },
      "Harms": {
        "score": 1,
        "evidence": "Adverse events were reported in 3% of the intervention group and 1% of the control group."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 1,
        "evidence": "This trial was funded by [source of funding]."
      }
    },
    "total_score": 21,
    "max_score": 25
  }
}